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CV 
Sten Rasmusen is associated professor in orthopaedic surgery at Aalborg University 
Hospital. SR is head of research within sports medicine and arthroscopy. Since 
November 2011 SR is head of the spearhead function “Motivated and maintained 
running, evidence based supported” at Aalborg University Hospital. The main 
research topics are multimodal pain treatment, musculoskeletal pain and running 
related injuries.  
There have been many years of research effort directed at the optimal clinical 
pathway targeted the causality between intervention and surgical pathophysiology 
against outcome. The interventions being preoperative information and training, 
minimal invasive surgery, multimodal pain management and early mobilization.  
Several studies present different aspect of musculoskeletal pain. More than 10 
publications investigate different aspects of running related injuries and pain. One 
study found no increased risk of injury in 931 novice runners using a neutral 
running shoe. More than 10 publications investigate patellofemoral pain in 3000 
adolescents. One study finds that half of 12-15 years old still have pain after one 
year. Further musculoskeletal pain is studied using conditioned pain modulation 
and quantitative sensory testing in osteoarthritis, patellofemoral pain in adolescents, 
total knee arthroplasty, lumbar spondylodesis, ankle sprain hip fracture and healthy 
volunteers. 
In June 2015 Sten Rasmussen completed the Harvard Medical School Global 
Clinical Scholars Research Training Program (GCSRT) with commendation for the 
Capstone Project Proposal. 
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ENGLISH SUMMARY 
Pain, convalescence and recovery are direct consequences of the surgical stress 
response during and after orthopaedic surgery. Different analgesic strategies aim at 
relieving pain as the primary treatment goal. Why is functioning and wellbeing not 
more important? We questioned whether pain treatment could influence recovery 
after arthroscopic surgery, hypothesised that multimodal pain treatment would 
provide a faster recovery after arthroscopic surgery and aimed to conduct a series of 
double blind placebo-controlled randomised trials of different analgesic treatment 
modalities after knee and ankle arthroscopy to test those hypotheses. 
Prior to our research start, no information was available within orthopaedic surgery 
on the surgical stress-reducing possibilities and pain reducing capacities of anti-
inflammatory drugs (NSAIDs), multimodal intra-articular pain treatment or 
multimodal intervention. In order to modulate and reduce this surgical stress 
response and subsequent pain to provide a faster recovery, we planned to study the 
effect of unimodal and multimodal intervention in arthroscopic surgery. We 
planned to study the unimodal effect of NSAIDs and secondly, the multimodal 
intra-articular pain treatment. 
In order to investigate the clinical effect of naproxen sodium on recovery, measured 
primarily as days until return to work after arthroscopy of the knee, 120 patients 
were randomised to either 550 mg naproxen sodium twice daily or placebo for 10 
days.  
In order to investigate the effect of intra-articular methylprednisolone plus 
morphine plus bupivacaine versus morphine plus bupivacaine or saline on recovery, 
measured primarily as time taken to return to work after arthroscopic knee 
meniscectomy, 60 patients were equally randomised into three groups. 
In order to investigate the effect of intra-articular methylprednisolone plus 
morphine plus bupivacaine versus morphine plus bupivacaine or saline on recovery, 
measured primarily as time taken to return to work after diagnostic knee 
arthroscopy, 60 patients were equally randomised into three groups. 
In order to investigate the effect of intra-articular methylprednisolone plus 
morphine plus bupivacaine versus saline on recovery, measured primarily as time 
taken to return to work after arthroscopic ankle debridement for impingement, 36 
patients were equally randomised into two groups. 
Time to return to work was reduced in all four trials at a statistically significant 
level. NSAIDs for 10 days after knee arthroscopy reduced time to return to work 
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from 17 (11-31) to 14 (10-31) days. Intra-articular treatment with morphine plus 
bupivacaine or methyl-prednisolone plus morphine plus bupivacaine after 
arthroscopic knee meniscectomy reduced time to return to work from 10 (1-30) to 5 
(1-14) to 3 (0-13) days. Intra-articular treatment with morphine plus bupivacaine or 
methylprednisolone plus morphine plus bupivacaine after diagnostic knee 
arthroscopy reduced time to return to work from 10 (1-14) to 5 (1-10) to 2 (0-15) 
days. Intra-articular treatment with methylprednisolone plus morphine plus 
bupivacaine after arthroscopic ankle debridement for impingement reduced time to 
return to work from 7 (1-52) to 2 (1-21) days.  
Hours of walking activity, use of crutches in days, days until pain-free, range of 
motion, synovial joint effusion and muscular strength were all to some extent 
influenced by active treatment in the four trials by a statistically significant amount.  
Additional analysis revealed that the surgical trauma influenced range of motion, 
synovial joint effusion and muscular strength by a statistically significant amount 
and that avoiding use of a tourniquet accelerated time to return to work by 4.88 
(3.01 – 6.75) days, a statistically significant amount. 
In the four trials, we have demonstrated a shorter duration of convalescence of 
several days with a reduction in the time to return to work after knee and ankle 
arthroscopy with the use of oral NSAIDs combined with bupivacaine plus morphine 
or combined with bupivacaine, morphine plus steroid.  
V 
DANSK RESUME 
Smerte, rekonvalescens og bedring tilbage til normal aktivitet er direkte 
konsekvenser til det kirurgiske stress respons under og efter ortopædkirurgiske 
operationer. Forskellige analgetiske behandlings strategier stræber efter som 
primært mål er at lindre smerten. Men hvorfor er funktion og velvære ikke mere 
vigtig? Vi satte spørgsmål ved, om ikke smertebehandling kan bedre tilbagevenden 
til normal aktivitet efter artroskopisk kirurgi, vi antog at multimodal smerte-
behandling kan afkorte bedring efter artroskopisk kirurgi og satte målet at 
gennemføre en dobbelt blinde placebo kontrollerede forsøg med forskellige 
analgetiske behandlings modaliteter efter knæ og ankel artroskopi. 
Forud for forskningsprojektets start var der ikke nogen tilgængelig viden indenfor 
ortopædisk kirurgi om kirurgisk stress reducerende muligheder eller 
smertereduktion med brug af non-steroide anti-inflammatoriske præparater 
(NSAIDs), multimodal intraartikulær smertebehandling eller multimodal 
intervention. 
For at modulere og reducere det kirurgiske stress respons og den efterfølgende 
smerte med henblik på at afkorte bedring planlagde vi at studere effekten af 
unimodal og multimodal intervention efter artroskopisk kirurgi. Vi planlage at 
undersøge den unimodale effekt af NSAID og efterfølgende en multimodal 
intraartikulær smertebehandling. 
For at undersøge den kliniske effekt af naproxen natrium på bedring målt som antal 
dage indtil genoptaget arbejde efter knæ artroskopi blev 120 patienter randomiseret 
til enten naproxennatrium 550 mg to gange dagligt eller placebo i 10 dage. 
For at undersøge den kliniske effekt af intraartikulær methyl-prednisolon plus 
morfin plus bupivacain versus morfin plus bupivacain eller placebo på bedring målt 
som antal dage indtil genoptaget arbejde efter artroskopisk knæ menisk resektion 
blev 60 patienter ligeligt randomiseret til tre grupper. 
For at undersøge den kliniske effekt af intraartikulær methyl-prednisolon plus 
morfin plus bupivacain versus morfin plus bupivacain eller placebo på bedring målt 
som antal dage indtil genoptaget arbejde efter diagnostisk knæ artroskopi blev 60 
patienter ligeligt randomiseret til tre grupper. 
For at undersøge den kliniske effekt af intraartikulær methyl-prednisolon plus 
morfin plus bupivacain versus morfin plus bupivacain eller placebo på bedring målt 
som antal dage indtil genoptaget arbejde efter artroskopisk debridement af ankelled 
impingement blev 36 patienter ligeligt randomiseret til to grupper. 
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Tilbagevenden til arbejde blev statistisk signifikant reduceret i alle fire forsøg. 
NSAID givet i 10 dage efter knæ artroskopi reducerede tilbagevenden til arbejde fra 
17 (11-31) til 14 (10-31) dage. Intraartikulær behandling med morfin plus 
bupivacain eller methylprednisolon plus morfin plus bupivacain efter artroskopisk 
knæ menisk resektion reducerede tilbagevenden til arbejde fra 10 (1-30) til 5 (1-14) 
til 3 (0-13) dage. Intraartikulær behandling med morfin plus bupivacain eller 
methylprednisolon plus morfin plus bupivacain efter diagnostisk knæ artroskopi 
reducerede tilbagevenden til arbejde fra 10 (1-14) til 5 (1-10) til 2 (0-15)dage. 
Intraartikulær behandling med methylprednisolon plus morfin plus bupivacain efter 
artroskopisk debridement af ankelled impingement reducerede tilbagevenden til 
arbejde fra 7 (1-52) til 2 (1-21) dage. 
Antal timer gående aktivitet, brug af krykker i dage, dage indtil smertefri, 
bevægeudslag, led ansamling og muskelstyrke blev i de fleste tilfælde statistisk 
signifikant påvirket af den aktive intervention i alle fire forsøg. 
Yderligere analyse af data afslørede at det kirurgiske traume statistisk signifikant 
påvirkede bevægeudslag, led ansamling samt muskelstyrke og at ingen brug af 
blodtomhed statistisk signifikant reducerede tilbagevenden til arbejde med 4.88 
(3.01 – 6.75) dage. 
I de fire forsøg har vi påvist en længerevarende effekt på flere dage med reduktion i 
tilbagevenden til arbejde efter knæ og ankel artroskopi med brug af NSAID 
kombineret med morfin plus bupivacain eller steroid plus morfin plus bupivacain.  
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CHAPTER 1. PREFACE 
The current Ph.D. thesis was submitted as part of the requirements for attaining the 
Ph.D. degree at the Faculty of Medicine and The Doctoral School in Medicine, 
Biomedical Science and Technology, University of Aalborg. 
The research for this thesis was carried out from 1990 to 2000 during my 
appointments as surgeon at the Department of Orthopaedic Surgery, Hjørring 
Hospital, and the Department of Orthopaedic Surgery, Copenhagen University 
Hospital in Hvidovre. 
The following papers and additional analyses based on the dataset from these 
randomised controlled trials formed the basis for this thesis:  
I. Rasmussen S, Thomsen S, Madsen SN, Rasmussen PJS, Simonsen OH. The 
Clinical Effect of Naproxen Sodium after Arthroscopy of the Knee. 
Arthroscopy 1993; 9: 375-80. 
II. Rasmussen S, Larsen AS, Thomsen ST, Kehlet H. Intra-articular 
glucocorticoid, bupivacaine and morphine reduces pain, inflammatory 
response and convalescence after arthroscopic meniscectomy. Pain 1998; 78: 
231-4. 
III. Rasmussen S, Lorentzen JS, Larsen AS, Thomsen ST, Kehlet H. Combined 
intra-articular glucocorticoid, bupivacaine and morphine reduces pain and 
convalescence after diagnostic knee arthroscopy. Acta Orthop Scand 2002; 
73: 175-8.  
IV. Rasmussen S, Kehlet H. Intraarticular glucocorticoid, bupivacaine and 
morphine reduces pain and convalescence after arthroscopic ankle surgery. 
Acta Orthop Scand 2000; 71: 301-4. 
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CHAPTER 2. INTRODUCTION 
2.1. BACKGROUND AND SYNOPSIS 
Pain, convalescence and recovery are direct consequences of the surgical stress 
response during and after orthopaedic surgery (Figures 1 and 2). Different analgesic 
strategies aim at relieving pain as the primary treatment goal. Why are function and 
wellbeing not more important? We questioned whether pain treatment could reduce 
the duration of convalescence after arthroscopic surgery, we hypothesised that 
multimodal pain treatment would provide faster recovery after arthroscopic surgery, 
and we aimed at performing a series of double blind placebo-controlled randomised 
trials of different analgesic treatment modalities after knee and ankle arthroscopy to 
test those hypotheses. 
Prior to our study start, no information was available within orthopaedic surgery on 
the surgical stress-reducing possibilities and pain-reducing capacities of non-
steroidal anti-inflammatory drugs (NSAIDs), multimodal intra-articular pain 
treatment or multimodal intervention. In order to modulate and reduce the surgical 
stress response and subsequent pain to provide faster recovery, we planned to study 
the effect of unimodal, and multimodal intervention in arthroscopic surgery and 
subsequently do translational research in other orthopaedic procedures.  
To the best of our knowledge, we are the first to perform studies on short duration 
treatment with NSAIDs after knee arthroscopy, combined intra-articular treatment 
with steroid, morphine and bupivacaine after knee and ankle arthroscopy (I-IV) and 
multimodal intervention after hip fracture and hip and knee arthroplasty and spine 
surgery (1-6) (Table 1.1).  
 
Unimodal effect of NSAIDs (I)                  04/90 to 04/92 
Multimodal intraarticular pain treatment (II-IV)   10/93 to 08/97 
                   10/93 to 02/00 
                   10/97 to 12/98 
Multimodal intervention (1-4)                                 03/99 to 12/00 
                   02/00 to 10/00 
                    04/99 to 05/01 
                   05/01 to 08/03 
Safety study of local infiltration (5)                 06/10 to 11/10 
Use of tourniquet study (6)                  06/11 to 06/13 
 
Table 1.1 Inclusion periods of patients in the studies. 
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Prostaglandins, bradykinins, leucotrienes, histamine and serotonins, liberated 
locally because of tissue damage, mediate post-arthroscopic effusion and synovitis 
(Figure 2.1). Pain and swelling are direct consequences. Convalescence and 
recovery after arthroscopy are also dependent on this cascade response.  
 
 
Figure 2.1 The action of NSAIDS and other medications on the inhibition of prostaglandins, 
inflammation, and pain. (Rasmussen 1993(I)) 
 
Factors in the surgical stress response with endocrine-metabolic and inflammatory 
changes relate to complications after surgery (Figure 2.2) (7-11). In order to prevent 
these complications, it is important to understand the stress reaction of each organ 
system. 
Minimal invasive surgical technique or pre-operative administration of high-dose 
steroids may prevent the inflammatory response. Neural blockade is best for 
prevention of the endocrine-metabolic response. Unimodal intervention cannot 
eliminate morbidity and mortality after major surgery. Thus, multimodal 
intervention with attenuation of the surgical stress response, effective dynamic 
treatment of pain, enforced mobilisation, and nutrition should be employed where 
possible (Figure 2.3). 
CHAPTER 2. INTRODUCTION 
15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 The surgical stress response 
 
Pain is the main reason for staying overnight in hospital after arthroscopic surgery 
and the main reason for not getting out of bed the day after major orthopaedic 
surgery. Pain is the dominant complaint during convalescence and the cause of 
unexpectedly long absences from work or recreational activities. Recovery 
following convalescence is dependent upon the efficacy of treatment where stress 
reduction, pain treatment and early mobilisation are important factors. 
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Figure 2.3 Control of the peri-operative period using pre-operative information, stress 
reduction, pain treatment, early mobilisation and nutrition 
 
 
The purpose of this thesis was to investigate whether the patterns and modalities of 
multimodal pain treatment after arthroscopic surgery would result in a faster 
recovery. 
 
2.2. RESEARCH QUESTION 
Can pain treatment influence recovery after arthroscopy? 
 
  
”control” of the peri-operative period
pre-op. stress pain mobili- nutrition
informat. reduction trtm. sation
reduced stress
reduced ”risk of complications” and convalescence
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2.3. HYPOTHESIS 
1. Naproxen sodium provides positive clinical effects compared to placebo after 
knee arthroscopy. 
2. Multimodal intra-articular pain treatment with (a) methylprednisolone, 
morphine and bupivacaine is superior in reducing the duration of 
convalescence compared to (b) morphine and bupivacaine, which is again 
superior to (c) placebo after arthroscopic knee meniscectomy. 
3. Multimodal intra-articular pain treatment with (a) methylprednisolone, 
morphine and bupivacaine is superior in reducing the duration of 
convalescence compared to (b) morphine and bupivacaine, which is again 
superior to (c) placebo after diagnostic knee arthroscopy. 
4. Multimodal intra-articular pain treatment with (a) methylprednisolone, 
morphine and bupivacaine is superior to (b) placebo in reducing the duration of 
convalescence after arthroscopic ankle surgery. 
 
2.4. AIMS 
To test the hypotheses above by conducting the following clinical trials: 
1. A randomised, double blind, placebo-controlled two-arm trial of post-
operative naproxen sodium after knee arthroscopy. 
2. A randomised, double blind, placebo-controlled three-arm trial of intra-
articular methylprednisolone plus morphine plus bupivacaine, morphine plus 
bupivacaine, or saline after arthroscopic knee meniscectomy.  
3. A randomised, double blind, placebo-controlled three-arm trial of intra-
articular methylprednisolone plus morphine plus bupivacaine, morphine plus 
bupivacaine, or saline after diagnostic knee arthroscopy. 
4. A randomised, double blind, placebo-controlled two-arm trial of intra-articular 
methylprednisolone plus morphine plus bupivacaine after arthroscopic ankle 
surgery.  
 
Two hundred and seventy-eight patients participated in the four trials (I-IV). After 
publication, we deleted patient identifiers from the data. The remaining research 
data of all 278 patients remained suitable for the Post Arthroscopic Pain Study 
(PAPS) dataset. In additional analyses of the dataset, we answered the question: 
‘Do we have evidence of confounding or effect modification influences due to type 
of surgery, use of a tourniquet and type of intra-articular analgesia on recovery after 
arthroscopic surgery?’  
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CHAPTER 3. METHODOLOGICAL 
CONSIDERATIONS 
3.1. TREATMENT WITH NSAIDS 
There was a considerable risk of side effects related to the use of NSAIDs in the 
late 1980s (12-16). One study found significantly more side effects in patients 
receiving NSAIDs for 6 weeks after arthroscopic surgery. Using NSAIDs compared 
to placebo, there was up to four times higher incidence of gastric side effects, 
heartburn and headache, with cardiovascular events being the most feared (16). 
Further, 6 weeks of treatment seems out of proportion for minor surgery such as 
knee arthroscopy. We planned a randomised controlled trial of 10 days treatment 
with NSAIDs compared to placebo, thereby potentially reducing these side-effects. 
We evaluated the time before returning to work as the primary measure of the 
duration of convalescence and hours of walking activity, muscular strength, range 
of motion, synovial effusion, and use of crutches together with pain profiles as 
appropriate secondary measures of recovery. 
 
3.2. MULTIMODAL INTRA-ARTICULAR TREATMENT 
NSAIDs (I, 12-17) and intra-articular bupivacaine or morphine can reduce post-
arthroscopic pain, but do not eliminate pain, inflammatory response or the duration 
of convalescence (18-20). The use of systemic administration of steroids may 
reduce inflammatory response and pain after dental surgery and abdominal surgery 
(21-24). Local intra-articular injections of steroids have been widely used for 
decades in various rheumatic diseases but no information was available on the use 
of intra-articular steroid after arthroscopic procedures (25). We planned three 
randomised controlled trials of combined intra-articular treatment with steroid, 
morphine and marcain, compared to morphine and marcain or placebo after 
arthroscopic knee and ankle surgery. We evaluated the time before returning to 
work as a measure of the duration of convalescence and hours of walking activity, 
quadriceps strength, range of motion, synovial effusion and use of crutches together 
with pain profiles as appropriate secondary measures of recovery. 
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3.3. SURGERY, TOURNIQUET AND ANALGESIA 
The key pathogenic factor is the surgical stress response with subsequent increased 
demands on organ function (Figure 2). This is mediated by the trauma-induced 
neuro-endocrine and inflammatory metabolic changes and activation of several 
biological cascade systems (Figure 3.1).  
The pathogenesis of postoperative morbidity relates to the various components of 
the surgical stress response. In arthroscopy, the types of surgery and the use or not 
of a tourniquet are components of the pathogenesis of post-operative morbidity that 
may influence outcome. 
We performed an additional analysis to evaluate the confounding or effect 
modification influences of type of surgery, use of a tourniquet and type of intra-
articular analgesia on recovery after arthroscopic surgery. 
 
3.4. PAIN 
Different orthopaedic procedures have their own characteristic pain pattern and 
need different analgesic treatment. Detailed information on multimodal pain 
treatment with the use of intra-articular pain treatment in combination with 
NSAIDS in arthroscopy and detailed information of multimodal pain treatment in 
combination with epidural analgesia in major orthopaedic surgery was not available 
prior to our study start but now is (1, 16). To our best knowledge, we are the first to 
study and assess the effect of post-arthroscopic intra-articular steroid in 
combination with morphine and bupivacaine (II-IV). 
Relief of post-operative pain is an important part of convalescence following 
orthopaedic procedures. Inadequate post-operative pain relief can prolong the 
duration of convalescence, precipitate or increase the duration of hospital stay, 
increase health care costs, and reduce patient satisfaction. Despite the benefits from 
effective pain treatment, surveys continue to indicate that acute post-operative pain 
remains inadequately managed (26). 
In pursuit of better post-operative pain control and ease of convalescence and 
recovery, surgical procedures, such as with arthroscopic surgery, are becoming 
minimally invasive and conducted in an ambulatory setting with the use of local 
anaesthetics.  
The experience of post-operative pain is subjective and registered in several ways 
(27-33). In our studies, we used a linear visual analogue scale (VAS). The VAS is 
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well-validated, reliable, accurate, simple and patient-friendly. The line is 10 cm 
long with endpoints labelled “no pain” and “worst possible pain”. Following 
instruction, the patients mark the line at a point corresponding to the intensity of 
their current pain. The method is valid in young patients but controversial in the 
elderly (31). We assessed pain on VAS in young patients at rest, during flexion and 
during walking (I-IV).   
 
3.5. CONVALESCENCE 
Convalescence is the time spent recovering from an illness or a treatment. It refers 
to the later stage when the patient gradually recovers and returns to normal. It 
includes the period of patient care after surgery during which they are required to 
attend regular follow-ups. Several factors can extend the duration of convalescence 
such as pre-operative expectation, post-operative pain and fatigue, lack of 
appropriate rehabilitation recommendations, social and cultural factors and 
interposed weekend (7-9, 17, 23-24).  
 
3.6. RECOVERY 
Recovery is gained after the end of convalescence. It is restoration or return to any 
former or better condition. Pain is the main cause of prolonged convalescence and 
delayed recovery following a variety of ambulatory surgical procedures (34) and 
major orthopaedic surgery (7-9, 35-37). Patients may return to work even though 
they may not have recovered. They may still have some pain and reduced function. 
Recovery has a number of components, one of which is return to work. A number 
of other measures of recovery, such as pain, reduced motion and strength, or 
swelling may disappear before return to work or persist after return to work. In our 
studies, we used return to work as the primary outcome measure of the duration of 
convalescence (Figure 3.1) (I-IV).  
 
3.7. DESIGN 
The dataset included measurement of time until return to work, hours of walking 
activity, quadriceps strength, range of motion, synovial effusion and use of crutches 
together with pain profiles. The incentives for accurate reporting were equal in all 
four studies using a daily questionnaire, thereby allowing linking of the four studies 
into one dataset. The linking of the datasets provides a more powerful method for 
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examining new research questions by providing a larger dataset than from a single 
study.  
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Intervention, convalescence and recovery. 
 
Randomisation 
The Consolidated Standards of Reporting Trials (CONSORT) statement from 1996, 
revised in 2001, clearly demonstrate that the randomised clinical trial (RCT) is the 
superior scientific instrument to assess the validity of results when planning a 
clinical investigation (38). Even though concealment of group allocation (39) and 
randomisation are the ‘gold standard’, these are not always possible with surgical 
patients (1-3). Randomised trials are the gold standard for determining the efficacy 
of an intervention. They are internally valid due to design and conduction in order 
to minimise bias (40-41). To be clinically useful, the results must also be relevant to 
the clinical setting. This external validity or ability to generalise depends on a 
representative study sample (40, 42-45). Another problem is the positive effect of 
being under study, which can affect both the health care staff and the patients in 
both control and intervention groups, and thereby affect the true result (46). 
 
  
Pain Recovery
Convalescence – Recovering
Intervention
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Sample size calculation 
Sample sizes in clinical orthopaedic research are often too small to ensure statistical 
significance and only 9% of the reviewed RCTs reported a sample size calculation 
(47). In our RCTs (I-IV), we addressed sample size and power before the initiation 
of the studies.  
A priori, we decided that the clinically relevant difference between control and 
intervention was the minimal relevant difference of interest (MIREDIFF) to look 
for in the sample size calculation. Further, we decided that the MIREDIFF should 
be close or equal to one standard deviation (SD). Since the primary outcome 
measurements are ordinal and probably normally distributed, we expected that one 
SD would equal one quartile of the measurements. 
Observations on the interval scale and the MIREDIFF formed the basis for 
calculation of sample size. The type I error (alfa, “α”) is when the null hypothesis is 
rejected given that the null hypothesis is true (α = P (reject H0 | H0 is true)). The 
type II error (beta, “β”) is when the null µhypothesis is accepted when the 
alternative hypothesis is in fact true (β = P (fail to reject the H0 | HA is true)). What 
we want to occur is that we reject the null hypothesis given that the alternative 
hypothesis is true, given a particular power of the study (power = P (reject H0 | HA 
is true = 1 – β)).  
We wanted to be stricter in the first RCT (I) and falsely reject the null hypothesis 
only 1% of the time (α = 0.01). Type I and type II errors were both set at 1% in the 
first RCT (I), with the risk of increasing the type II error. Therefore, we 
experienced a longer inclusion period than expected. 
Based on the diversity of arthroscopic procedures of the first study, we decided to 
only include meniscectomy or diagnostic procedures in the following two studies to 
reduce variability. Subsequently, we decided to reduce sample size and secure 
power at 80% in the following three RCTs (II-IV). To do this, we kept the 
difference between the null and alternative hypotheses at 1SD or increased the 
difference to 1.2 SD. Further, we increased the type I error rate to 5%.  
The sample size was calculated using the formula  
n = n1 = n2 = (σ*(z1-α/2 + z1-β)/δ)
2
 
where MIREDIFF = µ0 - µ1 = δ, SD = σ, and the statistics z1-α/2 and z1-β (Figure 3.2). 
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Fail to reject H0 Reject H0
α = P(reject H0 | H0 is true)
β = P(fail to reject the H0 | HA is true)
power = P(reject H0 | HA is true = 1 – β)
µ0
µ1
 
Figure 3.2 Sample size calculation 
 
Validity 
Sealed envelopes secured concealment of group allocation. Results were analysed 
by intention to treat. Two studies used several inclusion criteria (II-III) and one 
involved two institutions (III). These factors increase the internal validity and lower 
the external validity of our findings. The two studies complement each other and 
patients were consecutively enrolled. In the other studies (I, IV), inclusion and 
exclusion criteria were minimal, thereby increasing the external validity of our 
findings. We expected our studies to resemble other national and international 
studies of these cohorts of patients. 
 
Statistics 
When calculating sample size, we assume primary outcome measurements probably 
are normally distributed. Even though the primary outcome measurements look 
continuous and normally distributed, they are more likely ordered, and the 
magnitude between steps is uncertain. This makes parametric tests inappropriate 
since they require assumptions about the underlying distribution of data. This 
implies the use of non-parametric tests that do not make any or few assumptions 
about the underlying distribution of data. Data are presented using median and 
range. We have chosen Wilcoxon Rank Sum Test for independent samples. Where 
appropriate, we used Chi-square test and ANOVA with mixed model analysis (48). 
In additional analyses, we used StataIC13 to perform univariate and multivariate 
regression.  
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3.8. LITERATURE 
The following criteria identified relevant randomised trials: 
A. Computer-aided searching of Medline, Scopus, Embase and Cochrane trials 
register. The search, conducted from 1982 to September 2014, used the 
combination of the first two levels of the optimal search strategy for randomised 
trials (49). The search string for pain consisted of “post-operative pain” and 
“arthroscopy”. The search string for post-operative convalescence consisted of 
“convalescence” and “arthroscopy”. The search string for recovery was “recovery”, 
“work”, “sick leave”, “leisure activities” in combination with “arthroscopy”. The 
search string for intra-articular steroid consisted "Knee", "Knee-Joint", 
"Arthroscopy", "Adrenal-Cortex-Hormones", "Glucocorticoids Synthetic". The 
search string for intra-articular pain treatment with morphine and bupivacaine 
consisted of "Knee", "Knee-Joint", "Arthroscopy", “Intra-articular”, “bupivacaine” 
and “morphine”.  
B. Inspection of reference lists of retrieved reports and review articles. 
C. Contact with companies and selected authors in the field to find unpublished 
studies. D. Use of a personal archive. E. Subject-specific hand searches of the 
following journals from 1982: Acta Orthopaedica Scandinavia, American and 
British Journals of Sports Medicine, American and British Journals of Bone and 
Joint Surgery, and Scandinavian Journal of Medicine and Science in Sports. 
Using the inclusion and exclusion criteria, we found eligible trials. Each included 
trial underwent assessment of methodological quality and data extraction. 
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CHAPTER 4. SUMMARY OF RESULTS 
4.1. THE CLINICAL EFFECT OF NAPROXEN SODIUM AFTER 
ARTHROSCOPY OF THE KNEE 
Figure 4.1 illustrates the flow of patients and table 4.1 presents the characteristics of 
the patient groups. 
 
Figure 4.1 Consort flow chart of knee arthroscopy and RCT of oral naproxen 
versus placebo.  
Of the 127 patients assessed, 120 were eligible. Two patients in the naproxen group 
were lost to follow up. 
The trial revealed a decrease in the time to return to work by the use of naproxen 
compared to placebo during the 20 days of follow-up. The time to return to work 
was 14 (10-31) days for naproxen compared to 17 (11-31) days for placebo (P < 
0.0001 (Figure 4.2)).  There was a difference in walking activity the first 10 days (P 
= 0.01), in use of crutches (P = 0.01, days until pain-free (P = 0.0001), range of 
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motion (ROM) (P = 0.01), synovial effusion (P = 0.01) and quadriceps strength (P = 
0.04). 
 
Table 4.1 Demographic data in patients undergoing knee arthroscopy and RCT of 
oral naproxen versus placebo (median and range) (Rasmussen 1993 (I)). 
 
Figure 4.2 Box and whisker graph of the dependent variable days until return to 
work after knee arthroscopy for the independent variables naproxen and placebo 
(minimum, first quartile, median, third quartile and maximum) (P < 0.0001). 
CHAPTER 4. SUMMARY OF RESULTS 
29 
There was a difference in pain across the repeated measurements at 12 time points 
after knee arthroscopy (Figure 4.3) (P = 0.004). The measurement of pain was not 
specified in relation to rest or activity.  
 
 
Figure 4.3 Pain (mean and 95% confidence interval) at 12 time points during 10 
days after knee arthroscopy. 
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4.2. INTRA-ARTICULAR GLUCOCORTICOID, BUPIVACAINE 
AND MORPHINE REDUCES PAIN, INFLAMMATORY 
RESPONSE AND DURATION OF CONVALESCENCE 
AFTER ARTHROSCOPIC MENISCECTOMY 
Figure 4.4 illustrates the flow of patients and table 4.2 presents the characteristics of 
the patient groups. 
 
Figure 4.4 Consort flow chart of arthroscopic meniscectomy and RCT of intra-
articular saline, morphine+bupivacaine or glucocorticoid+morphine+bupivacaine.  
. 
Of the 141 patients assessed, 60 were eligible. None of the patients were lost to 
follow up.  
The trial revealed a reduction in the time to return to work by the use of 
methylprednisolone and bupivacaine plus morphine during the 10 days of follow-
up. The time taken to return to work was 3 (0-13) days for methylprednisolone + 
morphine + bupivacaine compared to 5 (1-14) for morphine + bupivacaine and for 
placebo, 10 (1-30) days (Figure 4.5) (P < 0.0001). 
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Table 4.2 Demographic data in patients undergoing arthroscopic meniscectomy 
and RCT of intra-articular saline (S), bupivacaine and morphine (B+M) or 
bupivacaine, morphine and methylprednisolone (B+M+MP). (median and range) 
(Rasmussen 1998 (II)). 
 
Figure 4.5 Box and whisker graph of the dependent variable days until return to 
work after arthroscopic knee meniscectomy for the independent variables placebo 
“1”, morphine plus bupivacaine “2” and methylprednisolone plus morphine plus 
bupivacaine “3” (minimum, first quartile, median, third quartile and maximum). 
There was a difference between the groups (P < 0.0001).  
 
MULTIMODAL PAIN MANAGEMENT AFTER ARTHROSCOPIC SURGERY 
32
 
There was a difference in hours of walking activity (P = 0.001), use of crutches (P = 
0.0001), days until pain-free (P < 0.0001), range of motion (P = 0.004), synovial 
effusion (P = 0.007) and quadriceps strength (P = 0.0001) 
There was a difference in pain across the repeated measurements at 14 time points 
after arthroscopic knee meniscectomy (Figure 4.6) (P = 0.0001).  The measurement 
of pain was performed at 90 degrees of knee flexion.  
 
 
Figure 4.6 Pain (mean and 95% confidence interval) at 90 degrees of flexion at 14 
time points during 10 days after arthroscopic knee meniscectomy. There was a 
difference between placebo (trt=1), morphine + bupivacaine (trt=2) and 
methylprednisolone + morphine + bupivacaine (trt=3) (P = 0.001). 
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4.3. COMBINED INTRA-ARTICULAR GLUCOCORTICOID, 
BUPIVACAINE AND MORPHINE REDUCES PAIN AND THE 
DURATION OF CONVALESCENCE AFTER DIAGNOSTIC 
KNEE ARTHROSCOPY  
Figure 4.7 illustrates the flow of patients and table 4.3 presents the characteristics of 
the patient groups. 
 
Figure 4.7 Consort flow chart of diagnostic arthroscopy and RCT of intra-articular 
saline, morphine+bupivacaine or glucocorticoid+morphine+bupivacaine.   
Of the 328 patients assessed, 60 were eligible. None of the patients were lost to 
follow up. 
The trial revealed a reduction in the time to return to work by the use of 
methylprednisolone and bupivacaine plus morphine during the 10 days of follow-
up. The time taken to return to work was 2 (0-15) days for methylprednisolone + 
morphine + bupivacaine compared to 5 (1-10) days for morphine + bupivacaine and 
10 (1-14) days for placebo (Figure 4.8) (P < 0.0001). There was a difference in 
hours of walking activity (P = 0.005), use of crutches (P < 0.0001), days until pain-
free (P < 0.0001), range of motion (P = 0.06), synovial effusion (P < 0.0001), 
quadriceps strength (P < 0.0001) 
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Table 4.3 Demographic data of patients undergoing diagnostic arthroscopy and 
RCT of intra-articular saline (S), bupivacaine and morphine (B+M) or 
bupivacaine, morphine and methylprednisolone (B+M+MP) (median and range). 
(Rasmussen 2002 (III)). 
 
Figure 4.8 Box and whisker graph of the dependent variable days until return to 
work after diagnostic knee arthroscopy for the independent variables placebo “1”, 
morphine plus bupivacaine “2” and methylprednisolone plus morphine plus 
bupivacaine “3” (minimum, first quartile, median, third quartile and maximum). 
There was a difference between the groups (P < 0.001).  
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There was a difference in pain across repeated measurements at 14 time points after 
diagnostic knee arthroscopy (Figure 4.9) (P < 0.0001). The measurement of pain 
was performed at 90 degrees of knee flexion. 
 
Figure 4.9 Pain (mean and 95% confidence interval) at 90 degrees of flexion at 14 
time points during 10 days after diagnostic knee arthroscopy. There was a 
difference between placebo (trt=1), morphine + bupivacaine (trt=2) and 
methylprednisolone + morphine + bupivacaine (trt=3) (P < 0.0001). 
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4.4. INTRA-ARTICULAR GLUCOCORTICOID, BUPIVACAINE 
AND MORPHINE REDUCES PAIN AND THE DURATION OF 
CONVALESCENCE AFTER ARTHROSCOPIC ANKLE 
SURGERY 
Figure 4.10 illustrates the flow of patients and Table 4.4 presents the characteristics 
of the patient groups. 
 
Figure 4.10 Consort flow chart of ankle arthroscopy and RCT of intra-articular 
saline or glucocorticoid+morphine+bupivacaine.   
Of the 68 patients assessed, 36 were eligible. None of the patients were lost to 
follow up. 
The trial revealed a reduction in the time to return to work by the use of 
methylprednisolone and bupivacaine plus morphine during the 10 days of follow-
up. The time taken to return to work was 2 (1-21) days for methylprednisolone + 
morphine + bupivacaine compared to 7 (1-52) days for placebo (Figure 4.11) (P = 
0.016).  
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Table 4.4 Demographic data in patients undergoing ankle arthroscopy and RCT of 
intra-articular saline or glucocorticoid+morphine+bupivacaine (median and 
range).  (Rasmussen 2000 (IV)) 
 
 
Figure 4.11 Box and whisker graph of the dependent days until return to work after 
ankle arthroscopy for the independent variables placebo “1” and 
methylprednisolone+ morphine+bupivacaine “2”. (P = 0.016). 
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There was a difference in hours of walking activity (P = 0.024), use of crutches (P < 
0.0001), days until pain-free (P < 0.0001), and synovial effusion (P = 0.003) but not 
in range of motion (P = 0.65).  
There was a difference in pain across repeated measurements at 14 time points after 
operative ankle arthroscopy (Figure 4.12) (P = 0.04). The measurement of pain was 
performed when walking.  
 
 
Figure 4.12 Pain (mean and 95% confidence interval) walking at 14 time points 
during 10 days after operative ankle arthroscopy. There was a difference between 
placebo (trt=1) and methylprednisolone + morphine + bupivacaine (trt=2) (P = 
0.041). 
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CHAPTER 5. ADDITIONAL ANALYSIS 
5.1. NAPROXEN SODIUM AFTER KNEE ARTHROSCOPY 
There was a variation in the results depending on the type of surgery when 
analysing the data from trial I. Based on this observation, we had two independent 
predictor variables, “naproxen or placebo” and “operative or diagnostic 
arthroscopy”. To investigate the effect of naproxen sodium after operative 
arthroscopy, we performed a univariate regression and a multivariate multiple 
regression analysis of the data at 10 days follow-up (Table 5.1 and 5.2). The 
multivariate multiple regression investigated the dependent variables (time to return 
to work, walking, use of crutches, days until pain-free, range of motion, synovial 
effusion and strength) to be predicted from Naproxen or placebo and operative or 
diagnostic arthroscopy. When adjusting for operative arthroscopy, there was still an 
effect of naproxen sodium on recovery (Table 5.2).  
 
 
Table 5.1 Univariate regression analysis of data at 10 days follow-up after knee 
arthroscopy of 120 patients. 
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Table 5.2 Multivariate multiple regression of data at 10 days follow-up after knee 
arthroscopy of 120 patients. 
 
 
5.2. INTRA-ARTICULAR PAIN TREATMENT AFTER KNEE 
ARTHROSCOPY 
Two studies (II-III) of intra-articular treatment included arthroscopic knee 
meniscectomy and diagnostic knee arthroscopy. When analysing the results of the 
two studies separately, we found a variation indicating that intra-articular treatment 
is less efficient after meniscectomy. To investigate whether the combined intra-
articular treatment reduces the duration of convalescence, we linked the data from 
these two studies and performed a univariate and a multivariate multiple regression 
analysis at 10 days follow-up (Tables 5.3 and 5.4). 
Adjusting for the surgical procedure, there was a positive effect of the combination 
of bupivacaine plus morphine plus methylprednisolone on all parameters (P < 
0.0001) (Table 5.4). 
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Table 5.3 Univariate regression analysis of data at 10 days follow-up after knee 
arthroscopy of 120 patients. 
 
Table 5.4 Multivariate multiple regression of data at 10 days follow-up after knee 
arthroscopy of 120 patients 
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5.3. USE OF TOURNIQUET IN KNEE ARTHROSCOPY 
In the study of NSAIDs after knee arthroscopy, we used a tourniquet to achieve a 
bloodless field (I). The two studies of intra-articular treatment after knee 
arthroscopy did not use a tourniquet (II-III). In the NSAIDs study, the median 
number of days for return to work was 16 (I), and for the linked study of intra-
articular treatment, 5 days (II-III). There was a difference in the time to return to 
work between use of a tourniquet or not with (P < 0.0001). In diagnostic knee 
arthroscopy, there was a difference (P < 0.0001), and in operative arthroscopy, there 
was a difference (P < 0.0001) (Figure 5.1). 
 
Figure 5.1 Box and whisker graph of the dependent days until work after knee 
arthroscopy for the independent variables tourniquet use and operative procedure 
of 240 patients. Diagnostic knee arthroscopy (P < 0.0001) and operative knee 
arthroscopy (P < 0.0001). 
 
A possible confounder may be the use of intra-articular treatment in study II and III 
and no use of post-operative NSAIDs in study I. Excluding intra-articular treatment 
and no post-operative NSAIDs, there was a difference in return to work between the 
use of a tourniquet or not with (P < 0.0001). For diagnostic knee arthroscopy, there 
was a difference (P < 0.0001) and for operative arthroscopy, there was a difference 
(P = 0.0001) (Figure 5.2). 
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Figure 5.2 Box and whisker graph of the dependent time to return to work after 
knee arthroscopy for the independent variables tourniquet use and operative 
procedure of 100 patients receiving oral NSAIDs and no intra-articular treatment. 
Diagnostic knee arthroscopy (P < 0.0001) and operative knee arthroscopy (P = 
0.0001). 
 
We found a variation in the results depending on the type of surgery and the use of 
a tourniquet or not. Based on this observation we had two independent predictor 
variables, “tourniquet” and “operative or diagnostic arthroscopy”. To investigate 
this, we performed a multivariate multiple regression analysis of the data at 10 days 
follow-up (Table 5.5). In the analysis are included 60 patients from the NSAIDs 
study (I), and 40 patients from the studies of intra-articular treatment who received 
post-operative NSAIDs and no intra-articular treatment (II-III).  
 
The analysis shows a statistically significant difference with/without tourniquet use 
on days until return to work, pain, range of motion, synovial effusion and 
quadriceps strength. The estimated effect of tourniquet use on the duration of 
convalescence was 4.88 (3.01 – 6.75) days. 
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Table 5.5 The effect of tourniquet use on recovery. Multivariate multiple regression 
of 100 patients receiving oral NSAIDs and no intra-articular treatment.  
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CHAPTER 6. DISCUSSION 
6.1. MAIN FINDINGS 
The results of the four studies (I-IV) indicate that post-operative use of oral 
NSAIDs and intra-articular multimodal pain treatment result in a faster recovery. 
The use of a tourniquet and the impact of surgical procedures hamper the effect of 
pain treatment on recovery. 
 
NSAIDs after knee arthroscopy 
Post-operative use of NSAIDs has a clinical effect on recovery after knee 
arthroscopy (I). There was an effect on time to return to work, hours of walking 
activity the first 10 days, use of crutches, days until pain-free, and range of motion. 
The effect was to some degree counteracted by the impact of the surgical procedure 
when measuring synovial effusion and quadriceps strength. In operative 
arthroscopy, there was a benefit of NSAIDs on effusion and quadriceps strength, 
but not in diagnostic arthroscopy. The improvement in muscular strength after 
operative arthroscopy may be due to both a reduction in effusion and the analgesic 
effect. The lack of improvement after diagnostic arthroscopy may be due to the 
surgical procedure being minor and the ensuing effusion and pain being minimal. 
Repeated measurement of pain during the first 10 post-operative days found an 
effect of treatment with NSAIDs to some degree but it did not persist. This was 
probably due to the measurement of pain not being specific in relation to rest or 
activity. 
 
Intra-articular analgesia after meniscectomy 
Intra-articular injection of methylprednisolone after arthroscopic knee 
meniscectomy had a clinical effect on recovery (II). There was an effect on time to 
return to work, use of crutches, hours of walking activity within the first 10 days, 
days until pain-free and range of motion. Morphine plus bupivacaine evaluated 
against placebo had a similar effect on recovery. In repeated measurement of pain 
between the three groups, there was an effect on pain at 90 degrees of flexion on 
pain during leg lift and stair walking.  
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Intra-articular analgesia after diagnostic knee arthroscopy 
After diagnostic knee arthroscopy, intra-articular injection of methylprednisolone 
had a clinical effect on recovery (III). There was an effect on time to return to work, 
hours of walking within the first 10 days, days with crutches, days until pain-free 
and synovial effusion. Morphine plus bupivacaine evaluated against placebo had a 
similar effect on recovery. In repeated measurement of pain between the three 
groups, there was an effect on pain at 90 degrees of flexion, during leg lift and stair 
walking.  
 
Intra-articular analgesia after operative ankle arthroscopy 
In operative ankle arthroscopy, there was a beneficial effect of multimodal intra-
articular treatment on recovery (IV). There was an effect on days until return to 
work, hours of walking activity within the first 10 days, use of crutches, days until 
pain-free and synovial effusion. There was an effect on repeated measurements of 
pain when walking. 
 
NSAIDs after operative knee arthroscopy 
An additional multivariate multiple regression analysis revealed the major 
counteracting effect of operative arthroscopy against the effect of NSAIDs on 
recovery (Table 5.1 and 5.2). The analysis proved the impact of surgical trauma and 
the necessity to distinguish between operative and diagnostic knee arthroscopy in 
future trials. Further, the analysis proved the limited efficacy of NSAIDs alone on 
recovery. 
 
Intra-articular analgesia after knee arthroscopy 
Two studies investigated the effect of intra-articular methylprednisolone, morphine 
and bupivacaine after arthroscopic knee meniscectomy and diagnostic knee 
arthroscopy (II-III). As in the previous study (I), when evaluating the results, the 
multimodal treatment seems more effective after diagnostic arthroscopy than after 
arthroscopic meniscectomy. The ANOVA analysis, especially, reveals a better 
effect of treatment over time after diagnostic than after arthroscopic knee 
meniscectomy. Again, the impact or size of the surgical trauma seems to counteract 
the effect of the multimodal intra-articular treatment, especially 
methylprednisolone. An additional multivariate multiple regression analysis proved 
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the effect of intra-articular treatment on recovery and revealed a minor 
counteracting effect of meniscectomy (Tables 5.3 and 5.4). 
 
Use of a tourniquet 
Pooling all data from the three studies showed that there was a clinical effect of 
tourniquet use on days until return to work (Figure 5.1). Excluding both intra-
articular treatment and no post-operative NSAIDs, the effect of a tourniquet was 
consistent. An additional multivariate multiple regression analysis of this subgroup 
proved the effect of tourniquet use on recovery (Table 5.5). There was an effect of 
tourniquet use on pain, range of motion, effusion and muscle strength. 
 
 
6.2. MONITORING SHORT-TERM POST ARTHROSCOPIC 
RECOVERY 
We used days until return to work, hours of walking activity, use of crutches, and 
days until pain-free to monitor the patient-reported recovery. Days to return to work 
was the primary outcome measure. For the physical examination at follow-up, we 
used range of motion, effusion and muscular strength to monitor signs of recovery. 
The patient-reported recovery measures reflect what matters to the patients rather 
than to the physicians. Moreover, the measures used carefully worded language that 
the patients use. The questionnaire was easily accepted and completed. Further, the 
selected measures evaluated independent physical recovery.  
The goals after arthroscopy are several, with a focus on return to work and normal 
activity (50). One is to restore range of motion to the same degree as that of the 
unaffected side in order to restore biomechanical alignment and function. Another 
goal is to restore muscular strength to ensure biomechanical support of the joint. 
Yet another is to restore gait to prevent disuse of the quadriceps. Full pain-free 
activity is important to prevent contracture and arthrofibrosis. In 2001, O`Connor 
(50) stated that range of motion, quadriceps strength and gait are the most important 
measures of post-operative recovery. In a recent review (15) of the effectiveness of 
post-operative physiotherapy after arthroscopic knee meniscectomy, the most 
important measures of recovery in 18 placebo-controlled randomised trials were 
days to return to work (2 trials), range of motion (8 trials), quadriceps strength (10 
trials), effusion (4 trials), activity pain (2 trials) and gait (1 trial). 
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The primary outcome and convalescence measure, days to return to work, was easy 
to monitor. This measure in our studies (I-IV) revealed clinically significant 
evidence of the efficacy of multimodal intra-articular treatment. Days to return to 
work also reflects the effectiveness of arthroscopy and may form the basis for cost-
benefit analysis. 
Hours of walking activity during the first 10 days after arthroscopy had a wide 
range from < 10 hours (I-II) to 189 hours (IV). This may indicate a reporting bias. 
In diagnostic knee arthroscopy (III) there was a tendency towards a non-significant 
increase in walking activity in the placebo group compared to that of the morphine 
plus bupivacaine group. The measure of hours of walking activity did not reveal 
any effect of tourniquet use or operative arthroscopy in subgroup analysis. 
Use of crutches the first 10 days after arthroscopy ranged from 0 to 10 in all of the 
four studies. The measure of use of crutches did not reveal any effect of tourniquet 
use or operative arthroscopy in subgroup analysis. 
Days until pain-free after the arthroscopy was easily monitored and revealed 
significance in all analyses. 
Range of motion at 10 days follow-up was easy to monitor even though the range 
was between 25 and 150 degrees (I) and between 75 and 160 degrees (II-III). The 
measure did not reveal significance in ankle arthroscopy. The measure did reveal 
significance in the other analyses. 
Effusion, measured as yes or no was statistically significant in all analyses. 
However, when quantified in this way, it is not easily monitored. 
Quadriceps strength classified as normal or reduced revealed significance in all 
analyses. However, when quantified in this way, it is also not easily monitored. 
In monitoring short-term recovery after arthroscopy, days to return to work seems 
to be the most efficient and use of crutches less efficient. According to the 
multivariate multiple regression analysis (Tables 3, 5 and 6), all but use of crutches 
seems to be useful in monitoring short-term recovery after arthroscopy. 
Days to return to work and time until pain-free seem to be the most important in 
evaluating the effectiveness of pain treatment after knee and ankle arthroscopy. 
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6.3. INTERPRETATION OF THE RESULTS AND COMPARISON 
WITH THE LITERATURE 
NSAIDs – efficacy and results 
Knee arthroscopy is a common procedure that has been routinely performed on an 
outpatient basis for more than two decades. Arthroscopy has spared the patients 
large incisions and decreased their morbidity, but not eliminated their pain. The 
internal surgical site, including the synovial tissue, the anterior fat pad and the joint 
capsule have free nerve endings that are capable of sensing painful stimuli and 
producing pain (51-53). 
The surgical trauma promotes expression of cyclooxygenase in both the peripheral 
nervous system and the central nervous system, leading to an increase in the release 
of prostaglandins, induction of pain and localised hyperalgesia and hypersensitivity. 
Therefore, inhibition of the prostaglandin release may be effective in preventing the 
development of pain after arthroscopy. The use of NSAIDs is common in the 
treatment of inflammation and pain resulting from rheumatic disease, sports and 
other injuries and less common in postoperative pain management. 
In outpatient surgery, effective pain relief is demanded and especially to allow early 
mobilisation. In the multimodal analgesic approach, there is still no consensus 
today as to the use of NSAIDs. There are limited guidelines concerning the peroral 
postoperative pain management after knee arthroscopy. The management varies 
from paracetamol only to combinations with codeine and morphine. The use of 
NSAIDs is in addition or as an alternative. In major surgery, there is an opioid 
sparing effect of NSAIDs and a shortening of hospital stay (23, 25, 54-56) but the 
benefit in terms of reduction in morphine-related adverse effects seems not to 
favour their use. 
Knee arthroscopy is associated with pain, swelling and discomfort requiring 
medication for several days after surgery (57-58). Swelling and discomfort further 
delay rehabilitation for up to 2 weeks after surgery (57-58). NSAIDs exert an opioid 
sparing effect in the post-operative period (59). That is particularly helpful in 
ambulatory surgical patients, in whom pain and nausea are common causes of 
delayed discharge (60). Further, patients unable to complete a rehabilitation 
program may be at increased risk of developing post-operative complications such 
as delay in strength recovery, prolonged knee stiffness and anterior knee pain (57-
58, 61). 
In a prospective study, we investigated the effects of 10 days of treatment with 
NSAIDs after arthroscopic surgery (I). Patients reported days to return to work, 
pain, use of crutches and hours of activity for 20 days. At the 10-day and 20-day 
follow-ups, we measured synovial effusion, range of movement and quadriceps 
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strength. When performing meniscectomy or other arthroscopic procedures, there 
was a significant effect of NSAID whereas after diagnostic arthroscopy, the effects 
of NSAIDs was minimal. This indicates that the benefits of NSAIDs relate to the 
severity of, and the reduction of the inflammatory response to, the surgical trauma. 
Further, the study demonstrates the primary outcome measures for evaluating 
modulation of the stress response are time to return to work and degree of activity. 
 
NSAIDs – literature review 
A methodological search in September 2014 found 33 studies for other randomised 
controlled trials of NSAIDs after arthroscopic knee surgery (16, 62-95). Most of the 
trials have investigated the effects of NSAIDS on pain measured on VAS and the 
use of other analgesics. Unfortunately, the trials had poor or moderate 
methodological quality. They used inadequately defined measures of post-operative 
pain not related to the inflammatory response, function or activity. Five studies 
compared different NSAIDs treatment (69, 73, 75, 77, 80) whereas 28 compared 
NSAIDs to other analgesics or placebo. Three studies only investigated bleeding 
and coagulation showing little or no effect on haemostasis (88, 90-91). Six studies 
measured pain but did not find an effect of NSAIDs (16, 65, 73-75, 85, 92), one 
was inconclusive (85) and 22 studies found an effect of NSAIDs (62-64, 66-72, 75-
82, 84-86, 89, 93).  
Prior to our study, Ogilvie-Harris (16) performed an evaluation of 6 weeks 
treatment with naproxen compared to placebo. Pre-allocation disclosure was 
insufficient and 22 of the 139 case reports were incomplete. Three patients were 
lost to follow-up. The patients receiving NSAIDs had less pain both at rest and 
during activity. The NSAIDs group had less synovitis and effusion. A significant 
number of patients (13/67) in the NSAIDs group had side effects such as heartburn, 
headaches and gastric upsets.  
In 1987, Drez (69) found less post-operative pain comparing a single dose of 
NSAIDs to propoxiphene plus acetaminophen. The study included 96 patients but 
only 52 patients had valid pain scores measuring post-operative pain for 6 hours. 
Two other studies found an effect of a single dose of NSAIDs (66, 89). 
Pedersen in 1993 (84) measured the effect of naproxen for 10 days compared to 
placebo and used a pain score which was a simple addition of each of the days of 
the first two weeks that had been measured daily using a four-grade scale. There 
was no difference when the patients were divided into therapeutic and diagnostic 
arthroscopy. The data were not useable for meta-analysis. 
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After 10 days treatment with NSAIDs, our study (I) showed a faster regain of 
quadriceps strength, range of movement and walking without aids compared to the 
placebo group, without any side effects. Only five other studies evaluated pain on 
activity (70-71, 76, 84, 86) and four studies evaluating recovery found no effect 
(71, 82, 84, 89). Smith (89) was not able to detect any difference in recovery 
between oral NSAIDs, intra-articular bupivacaine and NSAIDs plus bupivacaine. In 
Nelson’s (82) study, two-thirds of all patients returned to work 1 week after surgery 
with no difference between groups. From the studies by Fasting (71) and Pedersen 
(84), it was possible to extract data for a meta-analysis together with our study (I). 
From the studies, number of patients, mean and SD for NSAIDs and placebo were 
extracted (Table 6.1) and the results are presented in Figures 6.1 and 6.2. Based on 
the meta-analysis, there is a marginal effect of NSAIDs on days to return to work 
after knee arthroscopy. 
 
 
Table 6.1 Data extracted from Fasting (1992) (63), Pedersen (1993) (76) and 
Rasmussen (1993) (I) for meta-analysis; number of patients, mean and SD. 
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Figure 6.1 Meta-analysis of the effect of NSAIDs versus placebo on days to return 
to work after arthroscopic knee meniscectomy. Standardised mean difference SMD 
from 0 (P = 0.001). 
 
 
 Figure 6.2 Meta-analysis of the effect of NSAIDs versus placebo on days to return 
to work after diagnostic knee arthroscopy. Standardised mean difference SMD from 
0  (P< 0.0001). 
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Sufficient data that were suitable for a meta-analysis of the effect of NSAIDs versus 
other analgesics or placebo on pain measured on a VAS after knee arthroscopy 
were available in twelve studies (66, 69-71, 74, 77-79, 82, 85-86, 89). However, the 
study by Mardani-Kivi (78) was pre-emptive and hence, excluded. Of the nine 
studies excluded comparing NSAIDs to other analgesics or placebo on pain found 
no effect of NSAIDs (64, 72, 84, 92) whereas five did find an effect of NSAIDs 
(62, 68, 76, 85, 93) indicating there might be some publication bias in favour of 
studies showing an effect. The meta-analysis shows that when measuring pain 
shortly after arthroscopy, there is an effect of a single dose whereas the effect is 
significant but minimal when measuring pain several days after surgery using 
multiple doses of NSAIDs (Figure 6.3). This indicates that repeated measurement 
of pain during the first hours and days is more effective as a means to detect a 
difference. 
 
Figure 6.3 Meta-analysis of the effect of NSAIDs versus placebo on pain after knee 
arthroscopy. The significance tests of standardised mean difference for single dose 
studies (s) and multiple dose studies (m) was P < 0.0001 and P = 0.2 respectively, 
and overall, P < 0.0001. 
 
A meta-analysis of randomised controlled trials of the use of post-operative 
acetaminophen revealed a morphine sparing effect but did not reduce the morphine-
related adverse effects (94). Another review concluded that acetaminophen provides 
analgesic efficacy similar to that of NSAIDs following major orthopaedic surgery 
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and that acetaminophen may be an alternative to NSAIDs in high-risk patients (55, 
85). When using acetaminophen as a rescue analgesic, as in our randomised study 
of NSAIDs versus placebo, patients in the NSAIDs group did recover faster 
indicating that it may be appropriate to administer NSAIDs with acetaminophen 
since these two analgesics may act additively or synergistically to improve 
analgesia (I).  
There is an advantage in adding NSAIDs to patient-controlled analgesia with 
acetaminophen and morphine (100). The use of NSAIDs was associated with a 
decrease in the prevalence of post-operative nausea and vomiting and sedation, 
probably due to reduced use of morphine. Recent studies have demonstrated 
improved analgesia, shorter hospitalisation times, improved recovery and function, 
and decreased health-care costs with the use of COX-2 inhibitors in the multimodal 
management of pain following orthopaedic surgery (97-99), as we have proven in 
earlier studies (1-4).  
 
NSAIDs - limitations 
NSAIDs have a potentially major role in acute pain management because of their 
primary action in peripheral sites of sensitisation. NSAIDs can provide an effective 
adjunctive benefit to other analgesic therapy, including opioids and improve 
outcomes, not only by providing pain relief, but also by sparing patients some of the 
adverse effects associated with opioid use. Concerns about increased bleeding and 
inhibited wound healing and bone fusion have limited the use of NSAIDs. Bleeding 
and wound healing were not found to be a problem in this review of the literature in 
arthroscopic knee surgery (88, 90-91) and we did not experience any significant 
complications (I-IV). Most of the studies used unimodal pain treatment. Treatment 
with NSAIDs alone did not provide sufficient pain relief to allow normal function. 
Further, most of the literature fails to address the issue of pain during daily function 
and activity. In multimodal analgesia, it is appropriate to use NSAIDs. 
 
Intra-articular treatment with bupivacaine – efficacy and results 
The use of intra-articular administration of local anaesthetics following arthroscopy 
during the last 2-3 decades has improved post-operative analgesia.  
Recent in-vitro studies indicate a toxic effect on cartilage of the most commonly 
used local anaesthetics: bupivacaine, lidocaine and ropivacaine (100-104). The 
subsequent reduction in the use of local anaesthetics hampered the multimodal idea 
of post-operative pain treatment after arthroscopic surgery. A review in 2011(104) 
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concluded that the use of local anaesthetics may have a detrimental effect on human 
cartilage and in 2013, a study proved that high-flow infusion increased the risk of 
glenohumeral chondolysis compared to low-flow (105). Common across these 
studies is the lack of clinical implications due to exposure to varying concentrations 
of the local anaesthetics and resultant chondrolysis. The in-vitro studies use 
anaesthetic directly on the chondrocytes, not taking into consideration the dilution 
of the anaesthetics due to the use of and residual of 9% saline inside the joint after 
arthroscopy. Further, the study by Matsen (105) indicates that low-flow and low-
concentration of local anaesthetics may not be harmful. A report of 21 cases after a 
variety of different knee arthroscopic procedures indicated that the use of both high 
and low-flow-volume pump are related to knee chondrolysis (106). The use of a 
pump seems to be an additional factor to the toxicity of the local anaesthetic (105-
106). Whether or not it is the volume, pressure or flow is not clear. 
We did not experience any clinical signs or reports of chondrolysis in the groups 
involving 80 patients who received intra-articular bupivacaine (II-III). Recent 
studies within the last 5 years investigating intra-articular bupivacaine (108-114) do 
not report any incidence of chondrolysis.  
Even though bupivacaine is a long-acting local anaesthetic compared to other local 
anaesthetics, the effect on post-operative pain is short from a clinical point of view. 
A review evaluating the short-term effect within 4 hours after knee arthroscopy 
stated there is weak evidence for the use of intra-articular bupivacaine after 
arthroscopic knee surgery (115). Different operative procedures within the 
treatment groups and low sample sizes may explain these different results. Further, 
measurement of pain in activity may have more power to detect a difference (I-IV). 
There may be a longer-acting effect of intra-articular bupivacaine and measurement 
of pain during activity 24 hours after knee arthroscopy may be able to detect a 
clinical difference.  
 
Intra-articular treatment with bupivacaine – literature review 
A search in September 2014 for randomised double blind placebo controlled trials 
of intra-articular bupivacaine after knee arthroscopy revealed 24 studies (110, 114, 
116-141).  Up to one third of the studies, did not find an effect on pain score (119, 
123, 129, 134, 136, 138-140) or rescue medication (116, 118). Twenty studies were 
excluded because of a lack of measurements at 24 hours (129, 131), use of regional 
anaesthesia (117, 137), use of incisional anaesthetic (130), other intra-articular 
treatment (127) and inadequate data for analysis (110, 116, 118-123, 133, 135-136, 
139-141). Mean and SD of pain intensity on VAS were extracted from tables and 
figures. Only four studies measured pain in activity 24 hours after knee arthroscopy 
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(114, 124-126) whereas five measured pain at rest 24 hours after arthroscopy (128, 
130, 132, 134, 138) (Figure 6.4). 
 
Figure 6.4 Meta-analysis of the effect of bupivacaine versus placebo on pain during 
motion or at rest 24 hours after knee arthroscopy. The significance tests of 
standardised mean difference for pain during motion (m) and pain at rest (r) was P 
< 0.0001 and P = 0.7) respectively, and overall, P < 0.000). 
 
The analysis finds a relevant effect of bupivacaine 24 hours after knee arthroscopy 
when measuring pain during motion. This is in accordance with the 10-day pain 
profiles during activity in our studies (II-III). It may be due to a longer-acting 
neural response to local administration of anaesthetics. 
 
Intra-articular treatment with morphine – efficacy and results 
Before our studies (II-IV), application of intra-articular morphine proved the 
activation of peripheral opioid receptors in inflammation (20). We showed a longer 
effect of morphine combined with bupivacaine on pain, activity and inflammation 
demonstrating a prolonged analgesic effect beyond 24 hours (II-III). A review 
based on the author’s own two studies and seven other studies out of a total of 67 
randomised trials concluded there is no effect of intra-articular morphine (142). 
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Another review of 27 of 31 trials indicated that 5 mg of intra-articular morphine 
provides pain relief up to 24 hours when there is a minimum of 30% of maximum 
pain intensity (143). A third review (144) concluded that intra-articular morphine 
has a definite but mild analgesic effect. These reviews based their conclusions on 9 
(142), 25 (143) and 27 (144) randomised controlled trials respectively. Different 
validity criteria and methods of analysis have been used and surprisingly with an 
decreasing amount of included studies over time! 
The conflicting results of the reviews may be due to morphine having a better 
analgesic effect when there is a higher inflammatory response. One study concluded 
that for surgeries with a higher inflammatory response, intra-articular morphine has 
a better analgesic effect (145). A longer reduction of post-operative pain beyond 24 
hours due to injection of morphine together with bupivacaine, as in our studies (II-
III), supports the hypothesis of peripheral opioid receptor activation in 
inflammation. This judgement that intra-articular morphine can provide long-lasting 
effective post-operative analgesia is a confirmation of the hypothesis by Stein (20). 
 
Intra-articular treatment with morphine – a literature review 
To ensure a baseline for pain and intra-articular inflammation, studies on 
meniscectomy or cruciate ligament reconstruction alone were appropriate to be 
included in a review of the literature. A search in September 2014 for randomised 
trials comparing morphine to placebo found nine studies (126, 145-152).  Mean and 
SD of pain intensity on VAS was extracted from tables and figures. Measurements 
beyond 1 day were obtained from three studies (146 (3 days), 147 (7 days), 150 (4 
days)). Meniscectomy was performed in eight studies (126, 145-149, 151-152) and 
ACL reconstruction in three studies (145, 150, 152) (Figure 6.5).  
The analysis finds that morphine does have an effect when there is indication for 
meniscectomy or reconstruction of the anterior cruciate ligament. The effect is 
beyond 1 day and up to 7 days after surgery and relates to the pre-operative baseline 
pain and possible inflammation. This is consistent with our findings (II-III) and the 
measurements of the inflammatory response (II). This is also in accordance with the 
theory of the possible action of local analgesics on the surgical stress response 
either by a local anti-inflammatory or neuro-endocrine response. A possible 
systemic effect of intra-articular morphine may be negligible since the dose is 1-2 
mg. 
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Figure 6.5 Meta-analysis of the effect of morphine versus placebo on pain 1 day (d) 
or several days (ds) after knee arthroscopy. The significance tests of standardised 
mean difference for pain at 1 day (d) and pain at several days (ds) was P < 0.0001 
and P < 0.0001 respectively, and overall, P < 0.0001. 
 
Intra-articular treatment with corticosteroid – efficacy and results 
In the management of convalescence and pain after orthopaedic surgery, the 
potential value of corticosteroid treatment has received increasing attention 
especially within arthroscopy (II-IV, 52, 153-159), arthroplasty (160-175), and 
spine and other orthopaedic procedures (4, 176-181) during the last decade. 
The reported benefits of corticosteroid treatment are reduced pain, time of 
immobilisation and duration of convalescence. In arthroscopic knee surgery, intra-
articular (II-IV, 154, 156, 159, 182) and peroral (52, 158) treatment with 
corticosteroid has been reported as having some anti-inflammatory effect. In other 
surgical procedures, a pre-operative single dose of corticosteroid resulted in a 
reduced inflammatory and pain response (183). 
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The risk of complications such as septic arthritis reduces the potential of 
corticosteroid to enhance recovery. The risk of infection may increase after a single 
dose of glucocorticoids, especially after orthopaedic surgery. However, an attempt 
to evaluate the potential risks after hip and knee surgery failed due to small sample 
sizes and clinical heterogeneity (168). 
The annual incidence of septic arthritis in the general population is 0.02 to 0.05 per 
1000 (184). After knee arthroscopy, the risk of septic arthritis is 0.8 per 1000 and 
steroid injections prior to arthroscopy for degenerative changes may increase the 
risk to 2 per 1000 (185). After paediatric and adolescent knee arthroscopy, the 
incidence is 3 per 1000 (186). Post-operative infection rates in recent studies are 
from 0.02% to 1.13% (185-193). They report 433 infections after 542,394 (0.08%) 
arthroscopic procedures.  
A single dose of intra-articular corticosteroid may increase the risk of avascular 
bone necrosis and synovitis, or have an effect on cartilage. There is no side effect 
reported following single dose administration of corticosteroid in other surgical 
procedures (183). There is a benefit of intra-articular steroids in the treatment of 
osteoarthritis in reducing oedema, inflammation and pain (194-195). 
In an attempt to perform a safety study of intra-articular steroid after knee 
arthroscopy regarding an infection rate of 0.08%, a very large number of patients is 
needed, thereby making it impractical. If randomising 2000 patients to steroid or no 
steroid, the power to see a double risk of infection would only be 7.4%! Still there 
is a need to perform a safety study to reach some kind of a consensus. 
 
Intra-articular treatment with corticosteroid – literature review 
In two randomised studies, we were the first to investigate the effects of intra-
articular steroid after knee arthroscopy and to report a long-term effect on pain, 
function and inflammation (II-III). Four other studies have shown an effect on pain 
within 24 hours (154-155, 159, 182) and one up to 6 weeks after knee arthroscopy 
(156). Consensus is still lacking on whether corticosteroid offers clinically relevant 
benefits after arthroscopic surgery (II-IV, 154-155, 159, 182). A major reason for 
the lack of consensus is the potential risk of increased incidence of septic arthritis 
after arthroscopy. Septic arthritis should be an infrequent occurrence after 
arthroscopic surgery. In the six randomised trials after arthroscopic knee surgery, 
no infection occurred in 129 patients receiving intra-articular steroid (II-IV, 154-
155, 159, 182) (Figure 6.7). Pain profiles 24 hours after surgery were not significant 
in favour of steroid in two studies both including meniscectomy (II, 182). A 
possible explanation may be greater surgical trauma compared to the inclusion of 
diagnostic and other minor procedures in the other studies. 
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There may be a systemic effect of intra-articular glucocorticoids due to the high 
doses and slow release. It may explain the long-lasting analgesic effects. 
 
 
Figure 6.7 Meta-analysis of the effect of glucocorticoid versus placebo on pain 24 
hours after knee arthroscopy. The significance test of standardised mean was P < 
0.0001. 
The mechanism of action of intra-articular steroid in arthroscopic surgery is on the 
cellular level binding to the nucleus and by altering transcription. This reduces the 
amount of lymphocytes, macrophages and mast cells (196-197). In turn, 
phagocytosis, lysosomal enzyme release, and the release of inflammatory mediators 
are inhibited (198). Finally, the reduction in release of interleukins, leucotrienes and 
prostaglandins reduces inflammation and pain (199). 
 
Tourniquet 
The use of a tourniquet has obvious benefits to the surgeon. The advantages are a 
relatively bloodless field, improved surgical visualisation and diminished operating 
time. The pathophysiological effects of tourniquet use are noxious stimulation 
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(alterations in neural function, hyperalgaesia, ischemic pain), direct tissue 
compression, haemodynamic effects (reactive hyperaemia, post-operative 
haematoma, post-anoxic oedema) and micro vascular abnormalities (increased 
platelet adhesion, decreased endothelial cell function) (200-209). The risks are 
nerve paralysis, vascular injury, swelling, stiffness, delay in recovery of muscle 
power, changes in circulatory volume, limb hyperaemia on release of the 
tourniquet, potential cardiac or respiratory complications in patients with a poor 
cardiac reserve, and increased risk of deep-venous thrombosis. The possibility of so 
many complications contributes to the controversy about tourniquet use. 
There is poor knowledge of soft tissue damage due to tourniquet use. Measured by 
serum creatinine phospokinase, tourniquet use for less than 30 minutes seems safe 
(210). The ischemic changes in the skeletal muscle have been measured using 
microdialysis (211). The changes were also found in arthroscopic ACL 
reconstruction, where surgical trauma is not as severe as in total knee arthroplasty 
(211).  
In an additional analysis comparing the results where a tourniquet was used (I) 
compared to the results where tourniquet was not used (II-III), we found a negative 
effect of the tourniquet. The signs were clinically relevant regarding muscular 
strength, effusion and range of motion. Regarding outcomes, the patients reported a 
longer duration of time before return to work and increased pain. 
In a randomised study, we found improved knee range of motion, reduced pain and 
improved patient-reported outcome when not using the tourniquet in total knee 
arthroplasty (6). Two other recent randomised studies have reported the same 
results (212-213). Several randomised studies and meta-analyses have been 
published (6) and disagreements still seem to remain (218). The recent studies 
clearly demonstrate the benefits of not using a tourniquet. Not using a tourniquet 
may improve the effect of multimodal pain treatment in arthroscopic surgery. 
 
The surgical trauma 
From the additional analyses of data from our studies (I-III), it is obvious that 
increasing degrees of surgical trauma challenge the efficacy of the multimodal pain 
treatment.  
In 1916, Crile described the relationship between the degree of surgical trauma or 
tissue damage and the amount of acute pain and long-term post-operative pain 
(215). He advocated for a multimodal approach with the use of regional analgesia in 
addition to general anaesthesia, and even suggested pre-emptive analgesia to reduce 
post-operative morbidity (215). Post-operative persistent pain, now referred to as 
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central sensitisation, is both a neuropathic and inflammatory pain reaction (Figure 
1-3). It is an increased pain sensitivity described as hyperalgaesia and tactile 
allodynia, where there is persistent chronic pain and pain to light touch. Further, 
there is a reduction of efferent inhibitory transmission (217-217).  
The surgical trauma changes the excitation threshold of the peripheral and central 
neurons and increases the nociceptive afferent pathways. This may lead to 
persistent post-operative pain or central sensitisation of pain (218-220). Despite the 
advances that have been made in understanding pain, up to half the patients 
nevertheless still experience moderate to severe pain following surgery (220-222). 
Even though the presence of inflammation activates opioid receptors, not only post-
operative intra-articular morphine, but also pre-emptive intra-articular morphine 
does have an effect in a multimodal approach for arthroscopic meniscectomy (223). 
In arthroscopic-assisted acromioplasty and rotator cuff repair, a combination of 
intra-articular morphine, methylprednisolone and ropivacaine administered pre-
emptively, intra- operatively and post-operatively were superior to patient-
controlled post-operative analgesia (224). 
Abdominal surgeons were the first to document the value of multimodal or 
balanced analgesia (225). In a series of studies, we incorporated multimodal 
analgesia, using a combination of analgesics throughout the peri-operative period to 
control nociceptive and centrally stimulated pain (1-4). A better understanding of 
pain mechanisms and surgical stress response has encouraged the development of 
this multimodal strategy with the use of pre- and post-emptive analgesics, NSAIDs 
and continuous epidural and intra-articular treatment. Furthermore, we incorporated 
substantive pre-operative information, stress reduction, early active mobilisation 
and oral protein supplementation. The stress reduction included a substantive 
revision of peri-operative care programmes, peri-operative external heating, low 
volume therapy, reduced blood transfusion, oxygen supplementation, reduced use 
of opioids and minimal invasive surgery. This concept of multimodal intervention 
improved analgesia, reduced opioid-related adverse events, reduced complications, 
reduced hospital stay and improved rehabilitation and recovery. A part of the 
rationale for this strategy is the achievement of sufficient analgesia due to the 
additive or synergistic effects of the different analgesics. This allows a reduction in 
the dose of these drugs and thus a lower prevalence of adverse effects. 
This management strategy of employing multimodal and pre-emptive approaches, 
with an emphasis on preventing algesic flare prior to surgery and moderating or 
preventing development hyperalgesic states after surgery, has been proven to 
reduce hospitalisation, complications and chronic pain and increase patient 
outcomes (1-4). 
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Several other studies have used this understanding of the surgical trauma to 
implement and document the effect of multimodal pain treatment in arthroplasty 
(226-228) hip fracture (226, 229-230) and spinal surgery (231). 
 
6.4. METHODOLOGICAL CONSIDERATIONS AND LIMITATIONS 
Because of differences in methods applied in studies examining the effect of 
analgesia on pain after arthroscopic surgery, it is difficult to compare the results. 
Measurement of pain involves the use of 100 mm VAS or a range of other Likert 
scales, at different time points and in varied activities or at rest. Furthermore, the 
presentation of data can vary with the use of mean, SD and SEM, or median and 
range, and different graphic presentations. In addition, different endpoints, follow-
up times, and statistical methods are used. Even in this literature review, it was 
difficult to interpret and compare results. The strength in the studies of intra-
articular treatment in knee arthroscopy (II-III) was that we adjusted for the 
confounding of different surgical procedures experienced in the study of oral 
NSAIDs (I) and used activity-specific pain measurements. Another strength was the 
use of a consistent methodology in data management and analysis of results (II-IV). 
A limitation of the study of oral NSAIDs (I) was the different arthroscopic 
procedures which led to a post hoc subgroup analysis with different small sample 
sizes and hence a lower statistical power. The difference in the number of operative 
and diagnostic procedures, however reflects the unselected flow of patients and 
increases the external validity of the study. Moreover, the additional analyses 
performed in this review adjust for the confounding of operative and diagnostic 
arthroscopy. Another limitation was the repeated measurement of pain, not 
specified or related to rest or activity (I). The following studies used repeated 
measurement of pain related to a specific activity (II-IV). 
In the studies of intra-articular treatment in knee arthroscopy (II-III), the patients 
were highly selected, either meniscectomy or diagnostic, allowing a smaller group 
sample size. The internal validity therefore is high, but the external validity is low. 
Further, the use of three and not two groups makes the interpretation of the results 
difficult. The translation of the methods into general practice from each study alone 
may be difficult. The combined analyses of the data and interpretations of the 
results when compared with the literature increase the evidence for multimodal pain 
management. 
In the study of intra-articular treatment in ankle arthroscopy (IV), we included 
debridement for impingement and excluded ankle instability, thereby excluding 
more than one-third of eligible patients and reducing the external validity. Further, 
we experienced one deep infection that, in accordance with a risk incidence of deep 
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infection at 1-2% after ankle arthroscopy, hampers the use of intra-articular 
glucocorticoids in ankle arthroscopy. 
When analysing the repeated measurements of pain after intra-articular treatment 
(II-IV), we used the repeated measures analysis of variance test described by 
Matthews (48). When using this mixed effects model, taking treatment, time and 
change over time into consideration, we did find a level of significance. This is a 
very important finding and strengthens the importance of choosing an appropriate 
statistical package and the use of statistical advice when designing a study. 
These four studies and associated reviews of the literature indicate that there is a 
need for a better tool to measure the efficacy of pain treatment. Use of sufficient 
rescue medications in a well-designed setup usually finds no difference in pain on 
VAS. A priori, most patients will use rescue medications up until VAS < 30, so it is 
to be expected that there is likely to be no difference in VAS between the groups. 
However, analysis of the literature shows that this is not the result. Some studies 
either find no effect of rescue medication on VAS measured pain or find the 
opposite by suggesting an important relation between rescue medication and pain 
measured by VAS. Few studies have used time until first rescue medication as an 
outcome measure. From a study design perspective, it is possible to overlook an 
effect or to postulate an effect, when using only one of those methods and not 
measuring rescue medication and pain simultaneously (Figure 6.8).  
 
 
Figure 6.8Measuring efficacy using rescue medication or pain on VAS. It is 
possible in both methods to overlook an effect or postulate an effect when not 
measuring rescue medication and pain on VAS simultaneously. 
CHAPTER 6. DISCUSSION 
65 
In the figure, when plotting medication against pain on VAS, it is apparent how 
easy it is to postulate a significant difference in VAS when not considering use of 
rescue medication. In an intervention group, there might be a significant reduction 
in pain on VAS but an unrecognised increase in the use of rescue medication as 
indicated by the “no effect” arrow. This can explain the difficulties in evaluating the 
efficacy of intra-articular morphine after arthroscopic surgery.  Statistically, a 
regression analysis of the difference between the groups will reveal the answer. 
A repeated time to event analysis (232) including a pain measure and time interval 
between rescue doses may be a proper or better tool to measure pain management.  
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CHAPTER 7. FUTURE RESEARCH 
Peri-operative use of NSAIDs in orthopaedic surgery may impair wound and bone 
healing. This common interpretation of the current literature, to some degree, 
hampers the use of peri-operative NSAIDs, even in minor surgery such as 
arthroscopy. However, there is no evidence for an association between use of 
NSAIDs and bone healing. We have continued research in the use of NSAIDs and 
are conducting a double blind placebo-controlled study of NSAIDs on bone healing 
after distal radial fracture. To investigate whether NSAIDs reduce fracture healing, 
we are measuring bone density, bone composition, bone markers and clinical 
outcome. 
The intra-articular use of bupivacaine is toxic for the cartilage in animal studies and 
in human shoulder arthroscopy. In animal studies, standard concentration of 
bupivacaine is damaging to cartilage cells. It is necessary to investigate the safety of 
bupivacaine inside the knee joint after arthroscopy. Compared to animal studies, the 
concentration of bupivacaine may be lower than expected due to the use of saline 
during arthroscopy. Recently, we have investigated a slow release preparation of 
bupivacaine. We found a reduction in postoperative pain and morphine 
consumption up to 72 hours after soft tissue and bony surgeries. (Presented at the 
annual meeting of the American Society of Anaesthesiologists; October 11-15, 
2014; New Orleans, Louisiana). Another analgesic for possible use after knee and 
other small joint arthroscopy is topical lidocaine. Two pilot randomised placebo-
controlled studies indicate a reduction of escape medication after short duration 
knee arthroscopy (Presented at EFORT May 23-25, 2012. Berlin). We plan a larger 
placebo-controlled study after meniscal suture or resection. It is necessary to 
investigate the analgesic effectiveness of intra-articular morphine in placebo-
controlled design after plica resection and meniscectomy using repeated time to 
event analysis of escaped medication. A study with 1000 patients in each of two 
groups can address the safety of intra-articular steroids after arthroscopy. 
We are investigating the use of a tourniquet in total knee arthroplasty in a 
randomised controlled study. We are measuring local stress response with 
microdialysis and the stability of the implant with roentgen stereo metric analysis. 
We are investigating the benefit of minimal invasive surgical technique in lumbar 
spinal fusion. In a randomised controlled trial, minimal invasive surgical technique 
reduced length of stay and pain. The long-term safety, efficacy and cost-benefit are 
currently being monitored. Microdialysis is used to monitor the local and general 
surgical stress response and a computer model is used to monitor preservation of 
muscular function. The analysis of the impact of the surgical trauma on outcome 
indicates there is a need for monitoring the stress response in relation to the efficacy 
of multimodal pain treatment. We have planned a study using microdialysis to 
MULTIMODAL PAIN MANAGEMENT AFTER ARTHROSCOPIC SURGERY 
68
 
monitor the stress response and repeated time to event analysis of escape 
medication in arthroscopic knee surgery. The capacity of a single dose steroid or 
other analgesics such as pregabalin, gabapentin, fentanyl, local anaesthetics, 
NSAIDs and paracetamol, to reduce the surgical stress response and the duration of 
convalescence can be addressed in this setup. 
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CHAPTER 8. CONCLUSIONS 
NSAIDs for 10 days improve recovery after operative and diagnostic knee 
arthroscopy. The patients demonstrated a faster return to work. In the actively 
treated group, there was improved range of motion, less effusion, increased activity 
and less pain. The results showed better recovery over time. The effect is probably 
more to accelerate recovery than to increase the level of recovery achieved. When 
performing meniscectomy or other arthroscopic procedures, there were significant 
effects of NSAIDs whereas the effects of NSAIDs were minor after diagnostic 
arthroscopy. This indicates that the benefits of NSAIDs are related to the severity 
of, and the reduction of, the inflammatory response to surgical trauma. Further, the 
study demonstrates the primary outcome measure for evaluating modulation of the 
stress response should be degree of activity.  
NSAIDs have a potentially major role in acute pain management because of their 
primary action in peripheral sites of sensitisation. NSAIDs can provide an effective 
additional benefit to other analgesic therapy including opioids and improve 
outcomes, not only by providing pain relief, but also by sparing patients some of the 
adverse effects associated with opioid use. Concerns about increased bleeding and 
inhibited wound healing and bone fusion have limited the use of NSAIDs. 
However, 10 days treatment with NSAIDs without any side effects provides a faster 
return to work and restoration of normal activity. 
The main finding of intra-articular treatment in knee arthroscopy was a faster return 
to work by the addition of intra-articular methylprednisolone. Since joint effusion 
and acute phase response protein were reduced or eliminated, the mechanism may 
be anti-inflammatory. This potential to accelerate recovery must be weighed against 
the risk of complications. The reduction of the inflammatory response may 
theoretically alter wound healing. However, there is no clinically relevant wound to 
heal following knee arthroscopy and the inflammatory response may, in this type of 
operation, be considered an unwarranted response. Another potential complication 
is infection that seems to be negligible after a single dose. 
Another finding was the combined effect of bupivacaine and morphine, and the 
combined effect of bupivacaine, morphine and methylprednisolone on time taken to 
return to work. Both were shown to provide a faster return to work. Further, there 
was improved range of motion, improved muscular strength, reduced synovial 
effusion, increased activity and less pain. 
In ankle arthroscopy, the combined use of intra-articular bupivacaine, morphine and 
methylprednisolone is rational and effective in reducing pain and inflammation. 
The treatment had a pronounced and clinically relevant effect and provided a faster 
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return to work after arthroscopic ankle debridement. However, infection occurred in 
one of the members of the intervention group. Since purulent arthritis may have 
severe consequences, there is a need for large studies to investigate intra-articular 
treatment with glucocorticoids compared to the usual incidence of infection. 
An additional analysis of the study of oral NSAID and of intra-articular treatment 
after knee arthroscopy revealed the detrimental effect of surgical trauma on time 
taken to return to work and outcome. 
Comparing the study of oral NSAIDs after knee arthroscopy to the studies of intra-
articular treatment in knee arthroscopy, we found that avoiding the use of a 
tourniquet provides a faster return to work, improves range of motion and muscular 
strength, and reduces synovial effusion and pain. 
In the four trials, we have demonstrated a shorter duration of convalescence of 
several days with a reduction in time to return to work after knee and ankle 
arthroscopy with the use of oral NSAIDs combined with bupivacaine plus morphine 
or combined with bupivacaine, morphine plus steroid.  
Multimodal pain treatment after arthroscopy of the knee and ankle using NSAIDs 
and intra-articular bupivacaine, morphine and methylprednisolone reduce the time 
taken to return to work by more than 50% or up to 8 days. Use of a tourniquet and 
the degree of surgical trauma to some extent reduce the effect. There is a need for 
future trials to monitor the stress response to surgical trauma in relation to the 
efficacy of multimodal pain treatment. 
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The thesis is based on four randomized controlled trials. The main hypo-
thesis was that multimodal pain treatment provides faster recovery after ar-
throscopic surgery. 
NSAID was tested against placebo after knee arthroscopy. Intraarticular 
bupivacaine plus morphine plus steroid was tested against bupivacaine plus 
morphine and against saline in two trials after arthroscopic knee meniscecto-
my and diagnostic knee arthroscopy respectively. Intraarticular bupivacaine 
plus morphine plus steroid was tested against saline after operative ankle 
arthroscopy. 
Oral NSAID reduced time to work from 17 to 14 days after knee arthros-
copy. Intra-articular treatment with bupivacaine plus morphine and bupi-
vacaine plus morphine plus steroid after arthroscopic knee meniscectomy 
reduced time to work from 10 to 5 to 3 days. Intraarticular treatment with 
bupivacaine plus morphine and bupivacaine plus morphine plus steroid after 
diagnostic knee arthroscopy reduced time to work from 10 to 5 to 2 days. 
Additional analysis revealed that the surgical trauma and the use of tourni-
quet influenced recovery.
The thesis proves a reduction in the time to return to work after knee and 
ankle arthroscopy with the use of oral NSAIDs combined with bupivacaine 
plus morphine or combined with bupivacaine, morphine plus steroid.
